Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach

por Ochora, Douglas O., Mogire, Reagan M., Masai, Rael J., Yeda, Redemptah A., Mwakio, Edwin W., Amwoma, Joseph G., Wakoli, Dancan M., Yenesew, Abiy, Akala, Hoseah M.
Publicado 2023

Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs

por Wakoli, Dancan M., Ondigo, Bartholomew N., Ochora, Douglas O., Amwoma, Joseph G., Okore, Winnie, Mwakio, Edwin W., Chemwor, Gladys, Juma, Jackeline, Okoth, Raphael, Okudo, Charles, Yeda, Redemptah, Opot, Benjamin H., Cheruiyot, Agnes C., Juma, Dennis, Roth, Amanda, Ogutu, Benhards R., Boudreaux, Daniel, Andagalu, Ben, Akala, Hoseah M.
Publicado 2022